Article
Updated investigations of the role of methylenetetrahydrofolate reductase in human neural tube defects.
Clinical genetics - 1 Mar 2003
Rampersaud E, Melvin E C, Siegel D, Mehltretter L, Dickerson M E, George T M, Enterline D, Nye J S, Speer M C
Abstract excerpt
Folate supplementation appears to reduce the risk for neural tube defects (NTDs). Methylenetetrahydrofolate reductase (MTHFR) is a candidate gene in the folate metabolism pathway that has been extensively studied in different human populations. We examined the risk associated with having the thermolabile variant (TT) of MTHFR in a study of 175 American Caucasians with NTDs and their families. We found a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
